Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

SELL
$57.89 - $64.73 $64,431 - $72,044
-1,113 Reduced 15.75%
5,955 $345,000
Q2 2023

Aug 04, 2023

BUY
$63.71 - $70.74 $129,904 - $144,238
2,039 Added 40.54%
7,068 $451,000
Q1 2023

Apr 21, 2023

SELL
$65.71 - $74.53 $251,997 - $285,822
-3,835 Reduced 43.26%
5,029 $348,000
Q4 2022

Jan 25, 2023

BUY
$68.48 - $81.09 $90,119 - $106,714
1,316 Added 17.44%
8,864 $0
Q3 2022

Oct 13, 2022

BUY
$0.13 - $76.84 $173 - $102,658
1,336 Added 21.51%
7,548 $537,000
Q2 2022

Aug 15, 2022

BUY
$72.62 - $79.98 $47,057 - $51,827
648 Added 11.65%
6,212 $478,000
Q1 2022

May 02, 2022

BUY
$61.48 - $73.72 $67,935 - $81,460
1,105 Added 24.78%
5,564 $406,000
Q4 2021

Feb 07, 2022

BUY
$53.63 - $62.52 $6,381 - $7,439
119 Added 2.74%
4,459 $278,000
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $20,472 - $23,981
346 Added 8.66%
4,340 $257,000
Q2 2021

Aug 04, 2021

BUY
$61.91 - $67.42 $144,621 - $157,493
2,336 Added 140.89%
3,994 $267,000
Q1 2021

May 05, 2021

BUY
$59.34 - $66.74 $38,274 - $43,047
645 Added 63.67%
1,658 $105,000
Q4 2020

Feb 05, 2021

BUY
$57.74 - $65.43 $1,385 - $1,570
24 Added 2.43%
1,013 $63,000
Q3 2020

Oct 19, 2020

BUY
$57.43 - $63.64 $114 - $127
2 Added 0.2%
989 $60,000
Q2 2020

Jul 22, 2020

SELL
$54.82 - $64.09 $2,686 - $3,140
-49 Reduced 4.73%
987 $58,000
Q1 2020

Apr 28, 2020

BUY
$46.4 - $67.43 $92 - $134
2 Added 0.19%
1,036 $58,000
Q4 2019

Jan 22, 2020

BUY
$49.21 - $64.19 $98 - $128
2 Added 0.19%
1,034 $66,000
Q3 2019

Nov 01, 2019

BUY
$42.77 - $50.71 $2,224 - $2,636
52 Added 5.31%
1,032 $52,000
Q2 2019

Aug 05, 2019

SELL
$44.62 - $49.34 $1,115 - $1,233
-25 Reduced 2.49%
980 $44,000
Q1 2019

May 01, 2019

BUY
$45.12 - $53.8 $1,263 - $1,506
28 Added 2.87%
1,005 $48,000
Q4 2018

Jan 24, 2019

BUY
$48.76 - $63.23 $97 - $126
2 Added 0.21%
977 $51,000
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $11,810 - $13,321
214 Added 28.12%
975 $61,000
Q1 2018

May 04, 2018

SELL
$59.92 - $68.98 $9,407 - $10,829
-157 Reduced 17.1%
761 $48,000
Q4 2017

Feb 06, 2018

BUY
$59.94 - $65.35 $7,192 - $7,841
120 Added 15.04%
918 $56,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $44,073 - $50,864
798
798 $51,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $125B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track D'Orazio & Associates, Inc. Portfolio

Follow D'Orazio & Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D'Orazio & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on D'Orazio & Associates, Inc. with notifications on news.